Table 3 Postoperative therapy in nodal positive men
From: Outcomes of robot-assisted laparoscopic extended pelvic lymph node dissection for prostate Cancer
A) | ||||
Postoperative therapy | Nadir reached (n = 47) | Postoperative therapy | PSA persistence (n = 50) | |
Salvage EBRT | 12 (25.5%) | Adjuvant EBRT | 10 (20%) | |
Deferred ADT | 5 (10.6%) | Immediate ADT | 18 (36%) | |
Combination | 10 (21.3%) | Combination | 14 (28%) | |
None | 20 (42.6%) | Therapy declined | 8 (16%) | |
B) | ||||
Time to therapy | Nadir reached | PSA persistence | All pN+ | p-value |
Median time (months) to EBRT (range) | 13 (3-82) | 7 (2-110) | 9 (2-110) | 0.261 |
Median time (months) to ADT (range) | 21 (0-106) | 4 (1-89) | 5 (0-106) | 0.062 |